In India, 1 in 25 people have gene that causes heart failure

Jun 08, 2010
Sakthivel Sadayappan, Ph.D., of Loyola University Health System, studies a gene mutation in south Asian populations that causes heart failure. Credit: Loyola University Health System

One in 25 people from India and other south Asian countries carries a mutated gene that causes heart failure.

Studying this gene, and the protein it encodes, could lead to new treatments for heart failure, Loyola University Health System researcher Sakthivel Sadayappan, PhD, wrote in a recent review article in the Journal of Molecular and Cellular Cardiology. Sadayappan has studied the gene and protein for 15 years.

Investigating the protein could provide "a better understanding of the mechanics of during health and disease," Sadayappan and first author David Barefield wrote. Barefield is a graduate student and Sadayappan is an assistant professor in the Department of Cell and Molecular Physiology at Loyola University Chicago Stritch School of Medicine.

Previous studies by Sadayappan and other researchers found that about 4 percent of people who live in India, Pakistan, Sri Lanka, Indonesia and Malaysia carry the mutation. Carriers have about a 90 percent chance of developing heart failure after age 45.

About 60 million people worldwide, including about 40 million Indians, carry the mutation. (Sadayappan, who is from India, is not a carrier.) Sadayappan said the mutation likely arose in a single person roughly 33,000 years ago, and spread throughout south Asia.

The gene encodes for a protein, called cardiac myosin binding protein-C (cMyBP-C), that is critical for the normal functioning of the heart. In the mutated gene, 25 base pairs (DNA letters) are missing. As a result, the tail end of the protein is altered. Due to this modification, the protein is not properly incorporated into the functioning unit of called sarcomere. Consequently, the heart does not contract properly.

In younger carriers, the heart can compensate for this defect. But as the person ages, his or her heart is no longer able to compensate. becomes inflamed and does not work well, a condition called cardiomyopathy. The most common manifestation of cardiomyopathy is heart failure -- the heart can't pump enough blood to the rest of the body.

There is no current treatment to prevent heart failure in people who carry the mutated gene. However, a heart-healthy diet and exercise can delay the onset of heart failure, and heart failure drugs can manage symptoms.

Sadayappan said stem cell therapy could be a possible treatment. Stem cells would be taken from a patient's heart, genetically engineered to replace the mutated gene with a healthy gene, and then injected back in the patient's heart. But such stem cell therapy has not been tested. Nor is there a commercial test for the gene, Sadayappan said.

But Sadayappan and other scientists are actively researching how cMyBP-C functions. And improved understanding of this crucial protein, Sadayappan said, could lead to new drugs to treat heart failure.

Next year is the 40th anniversary of the discovery of cMyBP-C, and scientists still have much to learn about the function of this protein in the heart. Sadayappan's lab is helping lead the way by investigating the cardiomyopathy disease mechanism that could lead to new therapies to improve muscle function in patients. His long-term goal is to continue his cutting edge laboratory research to delineate the role of cMyBP-C function in the heart.

Explore further: Project pinpoints 12 new genetic causes of developmental disorders

add to favorites email to friend print save as pdf

Related Stories

I-1c gene therapy: Not such a good idea in heart failure?

Jan 12, 2010

Several lines of evidence, including the observation that the protein I-1 is downregulated in human failing hearts, have led to the suggestion that gene therapy to express a constitutively active form of the protein (I-1c) ...

Protein identified that helps heart muscle contract

Feb 16, 2010

UCSF researchers have discovered that a protein called B1N1 is necessary for the heart to contract. The findings, published in the Feb. 16 issue of the open access journal PLoS Biology, shed light not only on what makes ...

New heart failure device is tested

Oct 17, 2006

Physicians at 50 U.S. medical facilities are taking part in a multinational clinical trial of a device designed to help heart failure victims.

Recommended for you

Obese British man in court fight for surgery

Jul 11, 2011

A British man weighing 22 stone (139 kilograms, 306 pounds) launched a court appeal Monday against a decision to refuse him state-funded obesity surgery because he is not fat enough.

2008 crisis spurred rise in suicides in Europe

Jul 08, 2011

The financial crisis that began to hit Europe in mid-2008 reversed a steady, years-long fall in suicides among people of working age, according to a letter published on Friday by The Lancet.

New food labels dished up to keep Europe healthy

Jul 06, 2011

A groundbreaking deal on compulsory new food labels Wednesday is set to give Europeans clear information on the nutritional and energy content of products, as well as country of origin.

Overweight men have poorer sperm count

Jul 04, 2011

Overweight or obese men, like their female counterparts, have a lower chance of becoming a parent, according to a comparison of sperm quality presented at a European fertility meeting Monday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.